Myricanone
CAS: 32492-74-3
Ref. 3D-HBA49274
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.1<sup>2,6</sup>]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one
- Tricyclo[12.3.1.1<sup>2,6</sup>]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-
- Tricyclo[12.3.1.1~2,6~]Nonadeca-1(18),2,4,6(19),14,16-Hexaen-9-One, 3,15-Dihydroxy-16,17-Dimethoxy-
- 3,15-Dihydroxy-16,17-dimethoxytricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one
- Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one, 3,15-dihydroxy-16,17-dimethoxy-
Myricanone is a synthetic curcumin analog that is used to treat bowel disease, skin cancer, and other conditions. It has been shown to inhibit protein target nitro (PTN), a key enzyme in the synthesis of proteins involved in inflammation and cancer. Myricanone also inhibits the growth of cancer cells by inhibiting their ability to divide and proliferate. Myricanone has been found to have anti-inflammatory effects, which may be due to its inhibition of cyclooxygenase 2 (COX-2) and prostaglandin E2 (PGE2). Myricanone has also been shown to have sodium-dependent glucose cotransporter 1 (SGLT1) activity. The compound causes mitochondrial membrane depolarization by inhibiting complex I of the electron transport chain.
Propiedades químicas
Consulta técnica sobre: 3D-HBA49274 Myricanone
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
